Mobile

Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, afte...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-001253-29

Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, after first line chemotherapy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Evaluar la actividad antitumoral de Kahalalide administrado en infusion semanal de una hora a pacientes con cancer de pulmon no microcitico, estadio IIIB con derrame pleural y estado IV , tras una primera linea de quimioterapia.

Critère d'inclusion

  • Non Small Cell Lung Cancer Stage IIIB and IV after first Line Chemotherapy

Liens